...
首页> 外文期刊>Stem cell research >Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson’s disease patient carrying the heterozygous p.A30P mutation in SNCA
【24h】

Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson’s disease patient carrying the heterozygous p.A30P mutation in SNCA

机译:从帕金森病患者中携带杂合P.A30P突变的帕金森病患者的两种IPS细胞系(HIHDNDI001-A和HIHDNDI001-B)

获取原文

摘要

Dermal fibroblasts from a patient carrying a heterozygous c.88G??C mutation in the SNCA gene that encodes alpha-synuclein were reprogrammed to pluripotency by retroviruses. This pathogenic mutation generates the p.A30P form of the alpha-synuclein protein leading to autosomal dominantly inherited Parkinson’s disease (PD). Two clonal iPS cell lines were generated (A30P-3 and A30P-4) and characterised by validating the silencing of viral transgenes, the expression of endogenous pluripotency genes, directed differentiation into three germ layers in-vitro and a stable molecular genotype. These iPSC lines will serve as a valuable resource in determining the role of the p.A30P SNCA mutation in PD pathogenesis.
机译:来自携带杂合的C.88g的患者的皮肤成纤维细胞在SNCA基因中进行杂合C.88g的突变,将α-突触核蛋白编码为逆转录病毒的多能性。这种致病性突变产生了α-Synuclein蛋白的p.a30p形式,导致常染色体占遗传群帕金森病(Pd)。产生两条克隆IPS细胞系(A30P-3和A30P-4),其特征在于验证病毒转基因的沉默,内源性多能基因的表达,引导分化为体外三层和稳定的分子基因型。这些IPSC系列将作为测定P.A30P SNCA突变在PD发病机制中的作用的宝贵资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号